Opioid Crisis: The Hardest Blow to Pharma’s Reputation?

Opioid Crisis: The Hardest Blow to Pharma’s Reputation?

The media conversation around the biggest public health crisis in the US has immensely strengthened the already popular narrative portraying Big Pharma as an industry which prioritises profit over consumer well-being. Purdue Pharma, which was recently sued by nearly...
Biosimilars in the Media: Pharma’s New Market Disruptors?

Biosimilars in the Media: Pharma’s New Market Disruptors?

The legal twists and turns of the market have dominated the recent media discussion around biosimilars, while the general awareness of the drugs among patients, physicians and pharmacists remains relatively low. Using our Influencer Network Analysis (INA) methodology,...
G20 Summit 2019: How the Media Saw It

G20 Summit 2019: How the Media Saw It

The annual meetings of the world’s most powerful leaders are among the most widely covered global events in the media, with the messages conveyed by the Group of 20 (G20) making an immediate impact on markets and investment sentiments. As such, we might suggest that...

Pin It on Pinterest